ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
FTSE 100
8,262.08
1.38%
Dow Jones
44,296.51
0.97%
Gold vs US Dollar
2,715.28
0.00%
Brent Oil
74.65
0.00%
Bitcoin
98,040.22
-1.00%
Pepperstone
Advertisement
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Conduit Pharmaceuticals Inc (CDTTW)

  7. Conduit Pharmaceuticals Inc (CDTTW) News

Conduit Pharmaceuticals (CDTTW)

Conduit Pharmaceuticals Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:CDTTW
DateTimeSourceHeadlineSymbolCompany
20/11/202421:30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CDTTWConduit Pharmaceuticals Inc
20/11/202421:30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CDTTWConduit Pharmaceuticals Inc
20/11/202421:30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CDTTWConduit Pharmaceuticals Inc
19/11/202422:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CDTTWConduit Pharmaceuticals Inc
14/11/202422:27Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:CDTTWConduit Pharmaceuticals Inc
14/11/202422:24Edgar (US Regulatory)Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]NASDAQ:CDTTWConduit Pharmaceuticals Inc
14/11/202422:22Edgar (US Regulatory)Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]NASDAQ:CDTTWConduit Pharmaceuticals Inc
14/11/202422:20Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CDTTWConduit Pharmaceuticals Inc
06/11/202411:01Edgar (US Regulatory)Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:CDTTWConduit Pharmaceuticals Inc
04/11/202422:21Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:CDTTWConduit Pharmaceuticals Inc
04/11/202422:20Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:CDTTWConduit Pharmaceuticals Inc
04/11/202405:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:CDTTWConduit Pharmaceuticals Inc
01/11/202421:10Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:CDTTWConduit Pharmaceuticals Inc
01/11/202420:15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CDTTWConduit Pharmaceuticals Inc
28/10/202421:17Edgar (US Regulatory)Form ARS - Annual Report to Security HoldersNASDAQ:CDTTWConduit Pharmaceuticals Inc
28/10/202421:16Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:CDTTWConduit Pharmaceuticals Inc
28/10/202421:15Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:CDTTWConduit Pharmaceuticals Inc
24/10/202410:12Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:CDTTWConduit Pharmaceuticals Inc
18/10/202420:15Edgar (US Regulatory)Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:CDTTWConduit Pharmaceuticals Inc
16/10/202421:15Edgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsNASDAQ:CDTTWConduit Pharmaceuticals Inc
15/10/202421:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CDTTWConduit Pharmaceuticals Inc
07/10/202423:38Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CDTTWConduit Pharmaceuticals Inc
07/10/202423:36Edgar (US Regulatory)Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:CDTTWConduit Pharmaceuticals Inc
02/10/202421:02Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CDTTWConduit Pharmaceuticals Inc
29/05/202420:21GlobeNewswire Inc.A Presidio Property Trust Major Investment To Be Part of Russell 2000®NASDAQ:CDTTWConduit Pharmaceuticals Inc
06/10/202312:30GlobeNewswire Inc.Presidio Property Trust Announces Closing of Merger of Its Sponsored SPAC Murphy Canyon Acquisition Corp Now Trading as Conduit Pharmaceuticals (Nasdaq: CDT and CDTTW)NASDAQ:CDTTWConduit Pharmaceuticals Inc
 Showing the most relevant articles for your search:NASDAQ:CDTTW

Your Recent History

LSE
VAST
Vast Resources
LSE
POS
Plexus
LSE
CPI
Capita
LSE
ITV
Itv
NASDAQ
SMCI
Super Micro Computer
LSE
RRR
Red Rock Resources
LSE
SRSP
Sirius Petroleum
LSE
GDR
Genedrive
LSE
TPL
Tethys
LSE
TSLA
1x Tsla
LSE
GGP
Greatland Gold
LSE
SBTX
Skinbiotherapeutics
LSE
AAZ
Anglo Asian Mining
LSE
LIO
Liontrust Asset Management
LSE
DEC
Diversified Energy
LSE
SCLP
Scancell
Delayed Upgrade Clock
    ADVFN Logo
    InvestorsHub

    United Kingdom
    Company
    Business
    Popular
    Get The App
    App Store
    Google Play

    Support: +44 (0) 203 8794 460 | support@advfn.com

    By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

    © 2024 ADVFN PLC - All Rights Reserved

    BLACK FRIDAY

    ADVFN

    Celebrating 25 years Est 1999-2024

    Save up to 60%* for Level 2 Lite

    1 year 40%, 2 years 50% and *3 years 60%
    EU Flag

    *Across 3 years £2132.64 only £853.06